Pioneering research led by Brazilians describes the immune system's reactions in detail in the first living patient to ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

ENYO Pharma ("ENYO"), a clinical-stage biopharmaceutical company developing innovative therapies for kidney diseases, today ...

ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat immunoglobulin A nephropathy, address chronic kidney disease in specific ...

West Nile virus is the leading mosquito-borne infection in the United States. Neuroinvasive disease affects less than 1% but it can be fatal.

Employment rates for patients with end-stage kidney disease were higher for those with access to home hemodialysis or evening ...

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...

Kidney research reveals a complex picture of life-saving treatments that show genuine promise but deliver frustratingly mixed ...

Multidisciplinary care enhances kidney health and cardiovascular outcomes, but more research into models is needed, said Roy Mathew, MD.

Nearly 1 in 7 adults in the United States lives with chronic kidney disease, a condition that often advances quietly until ...

Common OTC painkillers like ibuprofen may increase heart attack and stroke risk. Learn which medications pose the greatest ...